HCA SIgned NCO 8 Cephied JOFOC.pdf

This document is a Sole Source Justification (SSJ) for the Department of Veterans Affairs (VA), specifically the Orlando VA Healthcare System, to establish a sole source procurement for Cepheid reagents and consumables. The contract will provide delivery of specific diagnostic testing reagents for molecular assays including MTB, MRSA, C. difficile, CARBA-R, SARS-CoV-2, Influenza A/B, RSV, Streptococcus Group A, and Multiplex Vaginal Panel (MVP) using Polymerase Chain Reaction (PCR) methodology.

The contract is a five-year agreement with a total estimated value of $4,986,000.00, broken into a base year and four one-year option periods at $997,200.00 each. Cepheid is the only authorized contractor capable of meeting the government's requirements, as they exclusively manufacture the Cepheid Infinity System, Cepheid Xpress testing equipment, and compatible reagents. The Orlando VA Healthcare System already owns the Cepheid testing equipment, purchased in 2021, and seeks to continue using these specialized molecular diagnostic platforms. The sole source justification was posted on SAM.gov on 1/24/2025, with an intended effective date of 11/15/24.